GPR34 and cervical carcinoma: As expected, the transcript levels of GPR34 were significantly (P < 0.05) higher in all the cervical cancer cell lines (CaSki, HeLa, HT-3, and ME-180) in comparison to the HcerEpic cervical epithelial cells (Figure 5(e)).